Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.60 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8426647 | 1.00 | EPHX1 (0.60) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL8991654 | 1.00 | EPHX1 (0.60) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL11589654 | 1.00 | EPHX1 (0.60) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL13387598 | 1.00 | EPHX1 (0.60) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL37472 | 1.00 | EPHX1 (0.60) | EPHX1CA12CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL11651995 | 0.97 | EPHX1 (0.58) | EPHX1CA12CA1CA2CA9 | |
| Hydrogen Peroxide SCHEMBL28079673 | 0.97 | EPHX1 (0.58) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL1080505 | 0.97 | EPHX1 (0.58) | EPHX1CA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL6487536 | 0.97 | EPHX1 (0.58) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL982024 | 0.97 | EPHX1 (0.56) | EPHX1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111393628-B | Application of organic metal complex and preparation method of polycarbonate prepolymer | 中国科学院过程工程研究所 | 2021-11-09 | — | — | CN | claimed |
| CN-111393628-A | Application of organic metal complex and preparation method of polycarbonate prepolymer | 中国科学院过程工程研究所 | 2020-07-10 | — | — | CN | claimed |
| WO-2016151508-A1 | METHOD AND APPARATUS FOR THE PRODUCTION OF DIARYL CARBONATE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-09-29 | — | — | WO | claimed |
| US-20250051259-A1 | METHOD FOR PRODUCING HIGHLY PURE DIARYL CARBONATE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-02-13 | — | — | US | disclosed |
| US-20240400496-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-4421063-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-08-28 | — | — | EP | disclosed |
| EP-4414357-A1 | METHOD FOR PRODUCING HIGH-PURITY DIARYL CARBONATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-08-14 | — | — | EP | disclosed |
| WO-2023068288-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | 旭化成株式会社 | 2023-04-27 | — | — | WO | disclosed |
| WO-2023058681-A1 | METHOD FOR PRODUCING HIGH-PURITY DIARYL CARBONATE | 旭化成株式会社 | 2023-04-13 | — | — | WO | disclosed |
| EP-2540697-B1 | METHOD FOR PRODUCING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2022-04-20 | — | — | EP | disclosed |
| CN-111393628-B | Application of organic metal complex and preparation method of polycarbonate prepolymer | 中国科学院过程工程研究所 | 2021-11-09 | — | — | CN | disclosed |
| US-4855418-A | Process for production of ceophalosporins | ELI LILLY AND COMPANY (US) | 1989-08-08 | — | — | US | disclosed |
| EP-0324562-A1 | 1-Carba(dethia)-3-cephem derivatives | ELI LILLY AND COMPANY (US) | 1989-07-19 | — | — | EP | disclosed |
| US-4820832-A | Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins | ELI LILLY AND COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| US-4820816-A | 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0299728-A2 | Carbonylation process for beta-lactam antibiotics | ELI LILLY AND COMPANY (US) | 1989-01-18 | — | — | EP | disclosed |
| US-4778884-A | REACTING TRIFLUOROMETHYLSULFONYLOXY COMPOUND WITH LITHIUM HALIDE IN APROTIC POLAR SOLVENT | PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) | 1988-10-18 | — | — | US | disclosed |
| US-4673737-A | ANTIBIOTICS/ | HARVARD UNIVERSITY (US) | 1987-06-16 | — | — | US | disclosed |
| US-4604242-A | Preparation of dialiphatic, dialicyclic, or di(aryl-substituted aliphatic) carbonates | THE DOW CHEMICAL COMPANY (US) | 1986-08-05 | — | — | US | disclosed |
| US-4490559-A | SYNTHESIS GAS AND A GROUP VII COMPOUND CATALYST | SHELL OIL COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051259-A1 | METHOD FOR PRODUCING HIGHLY PURE DIARYL CARBONATE | CA9, CA3, CEL | EPHX1 2730/4885CA12 15/4885CA1 8/4885 |
| US-20240400496-A1 | METHOD FOR PRODUCING DIPHENYL CARBONATE | HBB, HBG2, HBG1 | EPHX1 1985/4885CA12 21/4885CA1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.